Also, given the lack of therapies targeting the underlying haploinsufficiency in congenital aniridia, it is of particular interest to evaluate whether compensating for the deficiency of miR-204-5p could lead to PAX6 normalization with beneficial downstream effects in the cornea. This evidence concerns the gene PAX6 and aniridia.